☰

Marco Pravetoni, Ph.D. - Publications

Affiliations: 
2008 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Pharmacology
Tree Info Grants Similar researchers PubMed Report error

52/78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Powers N, Massena C, Crouse B, Smith M, Hicks L, Evans JT, Miller S, Pravetoni M, Burkhart D. Self-Adjuvanting TLR7/8 Agonist and Fentanyl Hapten Co-Conjugate Achieves Enhanced Protection against Fentanyl Challenge. Bioconjugate Chemistry. 34: 1811-1821. PMID 37758302 DOI: 10.1021/acs.bioconjchem.3c00347  0.338
2023 Crouse B, Miller SM, Muelken P, Hicks L, Vigliaturo JR, Marker CL, Guedes AGP, Pentel PR, Evans JT, LeSage MG, Pravetoni M. A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models. Npj Vaccines. 8: 107. PMID 37488109 DOI: 10.1038/s41541-023-00697-9  0.756
2023 Miller SM, Crouse B, Hicks L, Amin H, Cole S, Bazin HG, Burkhart DJ, Pravetoni M, Evans JT. A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice. Npj Vaccines. 8: 97. PMID 37429853 DOI: 10.1038/s41541-023-00694-y  0.382
2023 Martinez S, Harris H, Chao T, Luba R, Pravetoni M, Comer SD, Jones JD. The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis. Expert Opinion On Investigational Drugs. 1-5. PMID 36863002 DOI: 10.1080/13543784.2023.2187286  0.354
2023 Triller G, Vlachou EP, Hashemi H, van Straaten M, Zeelen JP, Kelemen Y, Baehr C, Marker CL, Ruf S, Svirina A, Chandra M, Urban K, Gkeka A, Kruse S, Baumann A, ... ... Pravetoni M, et al. A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl. Cell Reports. 42: 112049. PMID 36719797 DOI: 10.1016/j.celrep.2023.112049  0.729
2022 Crouse B, Wu MM, Gradinati V, Kassick AJ, Song D, Jahan R, Averick S, Runyon S, Comer SD, Pravetoni M. Efficacy and Selectivity of Monovalent and Bivalent Vaccination Strategies to Protect against Exposure to Carfentanil, Fentanyl, and Their Mixtures in Rats. Acs Pharmacology & Translational Science. 5: 331-343. PMID 35592436 DOI: 10.1021/acsptsci.1c00260  0.333
2022 Hamid FA, Marker CL, Raleigh MD, Khaimraj A, Winston S, Pentel PR, Pravetoni M. Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Vaccine. 40: 3244-3252. PMID 35469698 DOI: 10.1016/j.vaccine.2022.03.053  0.737
2022 Baehr CA, Wu MM, Pandit SG, Arias-Umana J, AuCoin D, Pravetoni M. . The Journal of Pharmacology and Experimental Therapeutics. PMID 35153198 DOI: 10.1124/jpet.121.001048  0.309
2021 Crouse B, Zhang L, Robinson C, Ban Y, Vigliaturo JR, Roy S, Pravetoni M. Housing conditions and microbial environment do not affect the efficacy of vaccines for treatment of opioid use disorders in mice and rats. Human Vaccines & Immunotherapeutics. 1-10. PMID 34411500 DOI: 10.1080/21645515.2021.1954442  0.367
2021 Huseby Kelcher AM, Baehr CA, Hamid FA, Hart GT, Pravetoni M. Contribution of Antibody-Mediated Effector Functions to the Mechanism of Efficacy of Vaccines for Opioid Use Disorders. Journal of Immunology (Baltimore, Md. : 1950). PMID 34281999 DOI: 10.4049/jimmunol.2100204  0.309
2021 Raleigh MD, King SJ, Baruffaldi F, Saykao A, Hamid FA, Winston S, LeSage MG, Pentel PR, Pravetoni M. Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder. Neuropharmacology. 108653. PMID 34126123 DOI: 10.1016/j.neuropharm.2021.108653  0.332
2020 Robinson C, Gradinati V, Hamid F, Baehr C, Crouse B, Averick S, Kovaliov M, Harris D, Runyon S, Baruffaldi F, LeSage M, Comer S, Pravetoni M. Therapeutic and Prophylactic Vaccines to Counteract Fentanyl Use Disorders and Toxicity. Journal of Medicinal Chemistry. PMID 33215913 DOI: 10.1021/acs.jmedchem.0c01042  0.326
2020 Baehr CA, Huseby Kelcher A, Khaimraj A, Reed DE, Pandit SG, AuCoin D, Averick S, Pravetoni M. Monoclonal antibodies counteract opioid-induced behavioral and toxic effects in mice and rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 32980813 DOI: 10.1124/jpet.120.000124  0.366
2020 Raleigh MD, Accetturo C, Pravetoni M. Combining a candidate vaccine for opioid use disorders with extended-release naltrexone increases protection against oxycodone-induced behavioral effects and toxicity. The Journal of Pharmacology and Experimental Therapeutics. PMID 32586850 DOI: 10.1124/Jpet.120.000014  0.496
2020 Gradinati V, Baruffaldi F, Abbaraju S, Laudenbach M, Amin R, Gilger B, Velagaleti P, Pravetoni M. Polymer-mediated delivery of vaccines to treat opioid use disorders and to reduce opioid-induced toxicity. Vaccine. PMID 32439214 DOI: 10.1016/J.Vaccine.2020.05.027  0.448
2020 Pravetoni M. Is the opioid use disorder epidemic impacting our immunological health? Brain, Behavior, and Immunity. PMID 32283290 DOI: 10.1016/J.Bbi.2020.04.022  0.325
2020 Lefevre EM, Pisansky MT, Toddes C, Baruffaldi F, Pravetoni M, Tian L, Kono TJY, Rothwell PE. Interruption of continuous opioid exposure exacerbates drug-evoked adaptations in the mesolimbic dopamine system. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32079024 DOI: 10.1038/S41386-020-0643-X  0.405
2020 Baehr C, Kelcher AH, Robinson C, Crouse B, Pravetoni M. Monoclonal Antibodies against Fentanyl and Fentanyl Analogs for Prevention of Opioid Overdose The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05425  0.387
2020 Raleigh MD, King SJ, Saykao AT, Baruffaldi F, Gradinati V, Winston S, Pentel PR, Pravetoni M. Functional in vivo characteristics of antibodies generated by an oxycodone vaccine The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03354  0.351
2019 Fulenwider HD, Nennig SE, Hafeez H, Price ME, Baruffaldi F, Pravetoni M, Cheng K, Rice KC, Manvich DF, Schank JR. Sex differences in oral oxycodone self-administration and stress-primed reinstatement in rats. Addiction Biology. e12822. PMID 31830773 DOI: 10.1111/Adb.12822  0.352
2019 Pravetoni M, Comer SD. Development of vaccines to treat opioid use disorders and reduce incidence of overdose. Neuropharmacology. PMID 31173759 DOI: 10.1016/J.Neuropharm.2019.06.001  0.438
2019 Baruffaldi F, Raleigh MD, King S, Roslawski M, Birnbaum A, Hassler C, Carroll FI, Runyon SP, Winston S, Pentel PR, Pravetoni M. Formulation and characterization of conjugate vaccines to reduce opioid use disorders suitable for pharmaceutical manufacturing and clinical evaluation. Molecular Pharmaceutics. PMID 31018096 DOI: 10.1021/Acs.Molpharmaceut.8B01296  0.38
2019 Robinson C, Baehr C, Schmiel SE, Accetturo C, Mueller DL, Pravetoni M. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders. Human Vaccines & Immunotherapeutics. PMID 30625019 DOI: 10.1080/21645515.2018.1558697  0.469
2019 Baehr C, Pravetoni M. Vaccines to treat opioid use disorders and to reduce opioid overdoses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 44: 217-218. PMID 30405185 DOI: 10.1038/S41386-018-0197-3  0.442
2018 Raleigh MD, Baruffaldi F, Peterson SJ, Le Naour M, Harmon TM, Vigliaturo JR, Pentel PR, Pravetoni M. Vaccination reduces fentanyl distribution to the brain and fentanyl-induced toxicity in mice and rats: a potential role for a prophylactic vaccine against fentanyl-induced overdose. The Journal of Pharmacology and Experimental Therapeutics. PMID 30409833 DOI: 10.1124/Jpet.118.253674  0.449
2018 Baruffaldi F, Huseby Kelcher A, Laudenbach M, Gradinati V, Limkar A, Roslawski M, Birnbaum A, Lees A, Hassler C, Runyon SP, Pravetoni M. Pre-clinical efficacy and characterization of candidate vaccines for treatment of opioid use disorders using clinically viable carrier proteins. Molecular Pharmaceutics. PMID 30240216 DOI: 10.1021/Acs.Molpharmaceut.8B00592  0.46
2018 Laudenbach M, Baruffaldi F, Robinson C, Carter P, Seelig D, Baehr C, Pravetoni M. Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose. Scientific Reports. 8: 5508. PMID 29615715 DOI: 10.1038/S41598-018-23777-6  0.466
2018 Raleigh MD, Laudenbach M, Baruffaldi F, Peterson SJ, Roslawski MJ, Birnbaum AK, Carroll FI, Runyon SP, Winston S, Pentel PR, Pravetoni M. Opioid dose- and route-dependent efficacy of oxycodone and heroin vaccines in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 29535156 DOI: 10.1124/Jpet.117.247049  0.397
2017 Raleigh MD, Peterson SJ, Laudenbach M, Baruffaldi F, Carroll FI, Comer SD, Navarro HA, Langston TL, Runyon SP, Winston S, Pravetoni M, Pentel PR. Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse. Plos One. 12: e0184876. PMID 29194445 DOI: 10.1371/Journal.Pone.0184876  0.488
2016 Pravetoni M. Biologics to treat substance use disorders: current status and new directions. Human Vaccines & Immunotherapeutics. 0. PMID 27441896 DOI: 10.1080/21645515.2016.1212785  0.351
2015 Laudenbach M, Tucker AM, Runyon SP, Carroll FI, Pravetoni M. The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence. Vaccine. 33: 6332-9. PMID 26409811 DOI: 10.1016/J.Vaccine.2015.09.015  0.365
2015 Laudenbach M, Baruffaldi F, Vervacke JS, Distefano MD, Titcombe PJ, Mueller DL, Tubo NJ, Griffith TS, Pravetoni M. The Frequency of Naive and Early-Activated Hapten-Specific B Cell Subsets Dictates the Efficacy of a Therapeutic Vaccine against Prescription Opioid Abuse. Journal of Immunology (Baltimore, Md. : 1950). 194: 5926-36. PMID 25972483 DOI: 10.4049/Jimmunol.1500385  0.41
2015 Kotecki L, Hearing M, McCall NM, Marron Fernandez de Velasco E, Pravetoni M, Arora D, Victoria NC, Munoz MB, Xia Z, Slesinger PA, Weaver CD, Wickman K. GIRK Channels Modulate Opioid-Induced Motor Activity in a Cell Type- and Subunit-Dependent Manner. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 7131-42. PMID 25948263 DOI: 10.1523/Jneurosci.5051-14.2015  0.681
2015 Kotecki L, Hearing M, McCall NM, de Velasco EMF, Pravetoni M, Arora D, Victoria NC, Munoz MB, Xia Z, Slesinger PA, Weaver CD, Wickman K. GIRK channels modulate opioid-induced motor activity in a cell type- and subunit-dependent manner Journal of Neuroscience. 35: 7131-7142. DOI: 10.1523/JNEUROSCI.5051-14.2015  0.636
2014 Pravetoni M, Pentel PR, Potter DN, Chartoff EH, Tally L, LeSage MG. Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats. Plos One. 9: e101807. PMID 25025380 DOI: 10.1371/Journal.Pone.0101807  0.397
2014 Pravetoni M, Vervacke JS, Distefano MD, Tucker AM, Laudenbach M, Pentel PR. Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats. Plos One. 9: e96547. PMID 24797666 DOI: 10.1371/Journal.Pone.0096547  0.444
2014 Taylor JJ, Laudenbach M, Tucker AM, Jenkins MK, Pravetoni M. Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse. Journal of Immunological Methods. 405: 74-86. PMID 24462800 DOI: 10.1016/J.Jim.2014.01.010  0.394
2014 LeSage MG, Raleigh MD, Pravetoni M, Tally L, Pentel P. Effects of a morphine-conjugate vaccine on heroin self-administration in rats Drug and Alcohol Dependence. 140: e119. DOI: 10.1016/J.Drugalcdep.2014.02.341  0.396
2013 Cornish KE, de Villiers SH, Pravetoni M, Pentel PR. Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditions. Plos One. 8: e82557. PMID 24312662 DOI: 10.1371/Journal.Pone.0082557  0.348
2013 de Villiers SH, Cornish KE, Troska AJ, Pravetoni M, Pentel PR. Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum. Vaccine. 31: 6185-93. PMID 24176492 DOI: 10.1016/J.Vaccine.2013.10.051  0.364
2013 Pravetoni M, Le Naour M, Tucker AM, Harmon TM, Hawley TM, Portoghese PS, Pentel PR. Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens. Journal of Medicinal Chemistry. 56: 915-23. PMID 23249238 DOI: 10.1021/Jm3013745  0.464
2013 Raleigh MD, Pravetoni M, Harris AC, Birnbaum AK, Pentel PR. Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats. The Journal of Pharmacology and Experimental Therapeutics. 344: 397-406. PMID 23220743 DOI: 10.1124/Jpet.112.201194  0.462
2012 Chen X, Pravetoni M, Bhayana B, Pentel PR, Wu MX. High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine. 31: 159-64. PMID 23123021 DOI: 10.1016/J.Vaccine.2012.10.069  0.344
2012 Pravetoni M, Raleigh MD, Le Naour M, Tucker AM, Harmon TM, Jones JM, Birnbaum AK, Portoghese PS, Pentel PR. Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine. 30: 4617-24. PMID 22583811 DOI: 10.1016/J.Vaccine.2012.04.101  0.462
2012 Pravetoni M, Le Naour M, Harmon TM, Tucker AM, Portoghese PS, Pentel PR. An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia. The Journal of Pharmacology and Experimental Therapeutics. 341: 225-32. PMID 22262924 DOI: 10.1124/Jpet.111.189506  0.461
2012 Pravetoni M, Keyler DE, Pidaparthi RR, Carroll FI, Runyon SP, Murtaugh MP, Earley CA, Pentel PR. Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities. Biochemical Pharmacology. 83: 543-50. PMID 22100986 DOI: 10.1016/J.Bcp.2011.11.004  0.32
2010 Arora D, Haluk DM, Kourrich S, Pravetoni M, Fernández-Alacid L, Nicolau JC, Luján R, Wickman K. Altered neurotransmission in the mesolimbic reward system of Girk mice. Journal of Neurochemistry. 114: 1487-97. PMID 20557431 DOI: 10.1111/J.1471-4159.2010.06864.X  0.597
2010 Anderson GR, Cao Y, Davidson S, Truong HV, Pravetoni M, Thomas MJ, Wickman K, Giesler GJ, Martemyanov KA. R7BP complexes with RGS9-2 and RGS7 in the striatum differentially control motor learning and locomotor responses to cocaine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1040-50. PMID 20043004 DOI: 10.1038/Npp.2009.212  0.614
2008 Perry CA, Pravetoni M, Teske JA, Aguado C, Erickson DJ, Medrano JF, Luján R, Kotz CM, Wickman K. Predisposition to late-onset obesity in GIRK4 knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 105: 8148-53. PMID 18523006 DOI: 10.1073/Pnas.0803261105  0.738
2008 Cruz HG, Berton F, Sollini M, Blanchet C, Pravetoni M, Wickman K, Lüscher C. Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 4069-77. PMID 18400906 DOI: 10.1523/Jneurosci.0267-08.2008  0.655
2008 Pravetoni M, Wickman K. Behavioral characterization of mice lacking GIRK/Kir3 channel subunits. Genes, Brain, and Behavior. 7: 523-31. PMID 18194467 DOI: 10.1111/J.1601-183X.2008.00388.X  0.625
2007 Anderson GR, Lujan R, Semenov A, Pravetoni M, Posokhova EN, Song JH, Uversky V, Chen CK, Wickman K, Martemyanov KA. Expression and localization of RGS9-2/G 5/R7BP complex in vivo is set by dynamic control of its constitutive degradation by cellular cysteine proteases. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 14117-27. PMID 18094251 DOI: 10.1523/Jneurosci.3884-07.2007  0.572
Low-probability matches (unlikely to be authored by this person)
2022 Baehr C, Robinson C, Kassick A, Jahan R, Gradinati V, Averick SE, Runyon SP, Pravetoni M. Preclinical Efficacy and Selectivity of Vaccines Targeting Fentanyl, Alfentanil, Sufentanil, and Acetylfentanyl in Rats. Acs Omega. 7: 16584-16592. PMID 35601290 DOI: 10.1021/acsomega.2c00820  0.298
2020 France CP, Ahern G, Averick S, Disney A, Enright HA, Esmaeli-Azad B, Federico A, Gerak LR, Husbands SM, Kolber B, Lau EY, Lao V, Maguire DR, Malfatti MA, Martinez G, ... ... Pravetoni M, et al. Countermeasures for preventing and treating opioid overdose. Clinical Pharmacology and Therapeutics. PMID 33113208 DOI: 10.1002/cpt.2098  0.289
2023 Crouse B, Baehr C, Hicks D, Pravetoni M. IL-4 Predicts the Efficacy of a Candidate Antioxycodone Vaccine and Alters Vaccine-Specific Antibody-Secreting Cell Proliferation in Mice. Journal of Immunology (Baltimore, Md. : 1950). 210: 1272-1280. PMID 36939374 DOI: 10.4049/jimmunol.2200605  0.284
2020 Crouse B, Robinson C, Huseby Kelcher A, Laudenbach M, Abrahante JE, Pravetoni M. Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders. Npj Vaccines. 5: 99. PMID 33101712 DOI: 10.1038/s41541-020-00247-7  0.282
2011 Pravetoni M, Keyler DE, Raleigh MD, Harris AC, Lesage MG, Mattson CK, Pettersson S, Pentel PR. Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. Biochemical Pharmacology. 81: 1164-70. PMID 21333633 DOI: 10.1016/J.Bcp.2011.02.004  0.275
2021 Stone AE, Scheuermann SE, Haile CN, Cuny GD, Velasquez ML, Linhuber JP, Duddupudi AL, Vigliaturo JR, Pravetoni M, Kosten TA, Kosten TR, Norton EB. Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge. Npj Vaccines. 6: 69. PMID 33986280 DOI: 10.1038/s41541-021-00329-0  0.27
2022 Rodarte JV, Baehr C, Hicks D, Liban TL, Weidle C, Rupert PB, Jahan R, Wall A, McGuire AT, Strong RK, Runyon S, Pravetoni M, Pancera M. Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding. Structure (London, England : 1993). PMID 36513069 DOI: 10.1016/j.str.2022.11.008  0.269
2012 LeSage MG, Shelley D, Pravetoni M, Pentel PR. Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist. Pharmacology, Biochemistry, and Behavior. 102: 157-62. PMID 22503967 DOI: 10.1016/J.Pbb.2012.03.026  0.257
2004 Mendoza-Baumgart MI, Pravetoni M, Sparber SB. Vasoconstriction caused by cocaine is enhanced by sodium salicylate: is inducible nitric oxide synthase mRNA related? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1294-300. PMID 14997177 DOI: 10.1038/Sj.Npp.1300421  0.252
2023 Baehr C, Kassick AJ, Vigliaturo J, Luengas D, Khaimraj A, Pravetoni M, Averick SE, Raleigh MD. Anti-Strychnine Immunoconjugate Reduces the Effects of Strychnine-Induced Toxicity in Mice. Acs Chemical Neuroscience. PMID 36952479 DOI: 10.1021/acschemneuro.2c00797  0.244
2022 Kiluk BD, Kleykamp BA, Comer SD, Griffiths RR, Huhn AS, Johnson MW, Kampman KM, Pravetoni M, Preston KL, Vandrey R, Bergeria CL, Bogenschutz MP, Brown RT, Dunn KE, Dworkin RH, et al. Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. Jama Psychiatry. PMID 36449315 DOI: 10.1001/jamapsychiatry.2022.4020  0.243
2007 Mendoza-Baumgart MI, Pravetoni M, Sparber SB. Inhibition of nitric oxide synthase enhances cocaine's developmental toxicity: vascular and CNS effects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 940-5. PMID 16880773 DOI: 10.1038/Sj.Npp.1301157  0.241
2021 Kassick AJ, Wu M, Luengas D, Ebqa'ai M, Tharika Nirmani LP, Tomycz N, Nelson TL, Pravetoni M, Raleigh MD, Averick S. Covalently Loaded Naloxone Nanoparticles as a Long-Acting Medical Countermeasure to Opioid Poisoning. Acs Pharmacology & Translational Science. 4: 1654-1664. PMID 34661081 DOI: 10.1021/acsptsci.1c00168  0.239
2021 Crouse B, Miller S, Robinson C, Gradinati V, Hicks L, Buhl C, Whitacre M, Evans J, Pravetoni M. Selected Toll‐like receptor agonists increase the efficacy of vaccines against fentanyl use disorder and overdose The Faseb Journal. 35. DOI: 10.1096/FASEBJ.2021.35.S1.03584  0.239
2021 Baehr C, Wu M, Hicks D, Hamid F, Luengas D, Pravetoni M. Anti‐fentanyl Vaccines and Monoclonal Antibodies are Effective in Prevention and Reversal of Fentanyl‐induced Overdose in Rats The Faseb Journal. 35. DOI: 10.1096/FASEBJ.2021.35.S1.03789  0.236
2017 Mavrikaki M, Pravetoni M, Page S, Potter D, Chartoff E. Oxycodone self-administration in male and female rats. Psychopharmacology. PMID 28127624 DOI: 10.1007/S00213-017-4536-6  0.234
2019 Kassick AJ, Allen HN, Yerneni SS, Pary F, Kovaliov M, Cheng C, Pravetoni M, Tomycz ND, Whiting DM, Nelson TL, Feasel M, Campbell PG, Kolber B, Averick S. Covalent Poly(lactic acid) Nanoparticles for the Sustained Delivery of Naloxone. Acs Applied Bio Materials. 2: 3418-3428. PMID 31497753 DOI: 10.1021/acsabm.9b00380  0.211
2022 Hicks D, Baehr C, Silva-Ortiz P, Khaimraj A, Luengas D, Hamid FA, Pravetoni M. Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development. Human Vaccines & Immunotherapeutics. 2122507. PMID 36194773 DOI: 10.1080/21645515.2022.2122507  0.208
2002 Robert C, McGraw S, Massicotte L, Pravetoni M, Gandolfi F, Sirard MA. Quantification of housekeeping transcript levels during the development of bovine preimplantation embryos. Biology of Reproduction. 67: 1465-72. PMID 12390877 DOI: 10.1095/Biolreprod.102.006320  0.205
2021 Raleigh M, King S, Saykao A, Robinson C, Baruffaldi F, Gradinati V, Winston S, LeSage M, Pentel P, Pravetoni M. IND‐enabling studies of vaccines to treat heroin and oxycodone use disorders The Faseb Journal. 35. DOI: 10.1096/FASEBJ.2021.35.S1.02440  0.201
2023 Luba R, Martinez S, Jones J, Pravetoni M, Comer SD. Immunotherapeutic strategies for treating opioid use disorder and overdose. Expert Opinion On Investigational Drugs. 32: 77-87. PMID 36696567 DOI: 10.1080/13543784.2023.2173062  0.18
2021 Dignan LM, Woolf MS, Ross JA, Baehr C, Holstege CP, Pravetoni M, Landers JP. A Membrane-Modulated Centrifugal Microdevice for Enzyme-Linked Immunosorbent Assay-Based Detection of Illicit and Misused Drugs. Analytical Chemistry. 93: 16213-16221. PMID 34807557 DOI: 10.1021/acs.analchem.1c04102  0.16
2024 Averick SE, Kassick AJ, Song D, Zhang B, Vigliaturo J, Luengas D, Silva-Ortiz P, Pravetoni M, Raleigh MD. Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP. Frontiers in Psychiatry. 15: 1366186. PMID 38550534 DOI: 10.3389/fpsyt.2024.1366186  0.12
2023 Song D, Crouse B, Vigliaturo J, Wu MM, Heimisdottir D, Kassick AJ, Averick SE, Raleigh MD, Pravetoni M. Multivalent Vaccination Strategies Protect against Exposure to Polydrug Opioid and Stimulant Mixtures in Mice and Rats. Acs Pharmacology & Translational Science. 7: 363-374. PMID 38357285 DOI: 10.1021/acsptsci.3c00228  0.12
2021 Raleigh M, Kassick A, Wu M, Luengas D, Pravetoni M, Averick S. A covalent poly(lactic acid) naloxone nanoparticle reduces fentanyl‐induced poisoning in rats The Faseb Journal. 35. DOI: 10.1096/FASEBJ.2021.35.S1.03106  0.061
2021 Comer SD, Pravetoni M, Coop A, Baumann MH, Cunningham CW. Potential unintended consequences of class-wide drug scheduling based on chemical structure: A cautionary tale for fentanyl-related compounds Drug and Alcohol Dependence. 221: 108530. DOI: 10.1016/J.DRUGALCDEP.2021.108530  0.061
Hide low-probability matches.